David Delburgo (Whitelab Genomics): Whitelab Genomics Uses AI and Deep Learning to Test Drug Effectiveness – Sep 13

On Tuesday, September 13, David Delburgo, President of Whitelab Genomics, reviewed the development of some genomic therapies thanks to artificial intelligence in Good Morning Business, presented by Laura Klozier and Christoph Yakubyshyn. Good Morning Business can be watched or listened to Monday through Friday on BFM Business.

09/13/2022 at 7:09 | Duration: 6:47

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker.